Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Strata Critical Medical (SRTA) Cash from Investing Activities (2019 - 2025)

Historic Cash from Investing Activities for Strata Critical Medical (SRTA) over the last 7 years, with Q3 2025 value amounting to $2.4 million.

  • Strata Critical Medical's Cash from Investing Activities rose 11896.25% to $2.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $55.5 million, marking a year-over-year increase of 122794.39%. This contributed to the annual value of -$1.0 million for FY2024, which is 10594.53% down from last year.
  • As of Q3 2025, Strata Critical Medical's Cash from Investing Activities stood at $2.4 million, which was up 11896.25% from $28.7 million recorded in Q2 2025.
  • Strata Critical Medical's 5-year Cash from Investing Activities high stood at $207.6 million for Q2 2022, and its period low was -$320.8 million during Q3 2021.
  • Moreover, its 5-year median value for Cash from Investing Activities was $3.1 million (2023), whereas its average is -$18.5 million.
  • Per our database at Business Quant, Strata Critical Medical's Cash from Investing Activities soared by 2084905.66% in 2022 and then plummeted by 54801.27% in 2024.
  • Quarter analysis of 5 years shows Strata Critical Medical's Cash from Investing Activities stood at $4.6 million in 2021, then tumbled by 90.02% to $462000.0 in 2022, then tumbled by 83.77% to $75000.0 in 2023, then soared by 5201.33% to $4.0 million in 2024, then tumbled by 39.69% to $2.4 million in 2025.
  • Its Cash from Investing Activities was $2.4 million in Q3 2025, compared to $28.7 million in Q2 2025 and $20.4 million in Q1 2025.